Product Code: RP-ID-10057072 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10057072
Market Overview:
Global Organic Pharmaceutical Excipients Market Size study, by Product (Oleo Chemicals, Carbohydrates, Petrochemicals, Protein, Others), by Application (Oral Formulation, Topical Formulation, Parenteral Formulation, Others) and Regional Forecasts 2018-2025
Global Organic Pharmaceutical Excipients Market to reach USD XX million by 2025.
Global Organic Pharmaceutical Excipients Market valued approximately USD XX million in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major driving factor of global Organic Pharmaceutical Excipients market are rising demands of generics, growing demand of pharmaceutical excipients due to the rising aging population and incidence of chronic diseases. In addition, advancement in functional excipient development and rapid growth in biopharmaceutical sector are also some major drivers that boosting the market growth. The major restraining factor of global organic pharmaceutical excipients are rising regulatory stringency and lengthy FDA process. Pharmaceutical excipients are the inactive substance for formulating final drug dosage forms. The excipients from the major part of any medical product and proportion of it when compared to Active Pharmaceutical Agent (API) exceeds two to three folds in any pharmaceutical preparations. Excipients usually help in improving the bioavailability of the active pharmaceutical ingredient pharmaceutical. It also helps in overall safety and effectiveness of the formulation during its storage and usually assures the consumer and manufacturers that the excipients quality will meet the international market.
The regional analysis of Global Organic Pharmaceutical Excipients Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America has accounted the leading market share of total generating revenue in across the globe owing to increase in number key market players in the region. Europe is also contributing maximum share in the global organic pharmaceutical excipients. Asia-Pacific region is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 due to the expansion of Asia-Pacific region is primarily due to countries such as China and India.
The major market player included in this report are:
• DowDuPont
• Roquette
• Ashland
• BASF
• Kerry
• Evonik Industries
• Croda
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
§ Oleo Chemicals
§ Carbohydrates
§ Petrochemicals
§ Protein
§ Others
By Application:
§ Oral Formulation
§ Topical Formulation
§ Parenteral Formulation
§ Others
By Regions:
§ North America
o U.S.
o Canada
§ Europe
o UK
o Germany
§ Asia Pacific
o China
o India
o Japan
§ Latin America
o Brazil
o Mexico
§ Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
Target Audience of the Global Organic Pharmaceutical Excipients Market in Market Study:
§ Key Consulting Companies & Advisors
§ Large, medium-sized, and small enterprises
§ Venture capitalists
§ Value-Added Resellers (VARs)
§ Third-party knowledge providers
§ Investment bankers
§ Investors
Roquette
Ashland
BASF
Kerry
Evonik Industries
Croda
Related Reports
Proof of Quality & Reliability
